Introduction
E2F is a family of heterodimeric transcription factors composed of one E2F polypeptide and one DP polypeptide (Slansky and Farnham, 1996; Dyson, 1998) . Six genes for E2F and two genes for DP proteins have been described in mammals. E2F-1-3 have a cyclin A binding domain at their N-terminus and localize in the nucleus in transient transfection experiments, while E2F-4 and -5 have no cyclin A binding domain and localize in the cytoplasm. E2F-1-3 preferentially bind pRb whereas E2F-4 and -5 have higher anity for p107 and p130 than pRb. E2F-6 lacks both a cyclin A binding domain in the Nterminus and a transactivation domain in C-terminus, and appears to function as a dominant negative repressor of E2F in vivo and in vitro. DP-1 and DP-2 can form heterodimers with any member of the E2F protein family and synergistically enhance the DNA binding and transactivation activity of E2F proteins (see Dyson, 1998) . In transient transfection experiments DP-1 localizes in the cytoplasm, while DP-2 localizes in the nucleus (Magae et al., 1996; de la Luna et al., 1996) . Although it is assumed that each E2F/DP heterodimer has a distinct role in regulating gene expression in speci®c stages of the cell cycle in cells or tissues, the precise function of dierent combinations of E2F/DP heterodimers has been remained elusive.
It has been reported that ectopic expression of E2F-1 with an adenovirus vector induces apoptosis (DeGregori et al., 1997) . Other E2F subunits were relatively inactive in this assay. In contrast, ectopic expression of all the E2F proteins except E2F-6 induce DNA synthesis of serum starved cells (DeGregori et al., 1997) . E2F-1 speci®cally induces p19ARF (Bates et al., 1998; de Stanchina et al., 1998; Robertson and Jones, 1998) , which stabilizes p53 by binding Mdm-2 (Pomerantz et al., 1998; Zhang et al., 1998; Kamijo et al., 1998) . This suggests that E2F-1 induces apoptosis by increasing expression level of p53 through transactivation of the ARF promoter. In contrast, p53-independent apoptosis does not require the C-terminal region of E2F-1 which functions in transactivation and in interaction with pRb. Rather only the DNA-binding domain is necessary for the p53-independent apoptosis (Hsieh et al., 1997; Phillips et al., 1997) . Moreover, a point mutation in the Rb-binding domain of E2F-1 enhanced apoptosis by E2F-1 (Shan et al., 1996) .
Studies with E2F-1 de®cient mice suggest that E2F-1 is required for apoptosis rather than S phase entry in vivo. An unusually high incidence of tumors and abnormal maturation of T cells due to impaired apoptosis of thymocytes were observed in E2F-1 de®cient mice (Yamasaki et al., 1996; Field et al., 1996) . On the other hand, Bargou et al. (1996) have reported that expression of dominant negative form of E2F-2 prevented apoptosis of human epithelial cells and enhanced the oncogenic capacity of the cells. E2F-2 and E2F-4 also have been observed to induce apoptosis similar to E2F-1 in astrocytoma (Dirks et al., 1998) . Thus, the role of each E2F protein in the regulation of apoptosis is unclear.
To address the role of DP-1 protein in cell cycle progression and apoptosis, we established Chinese hamster cell lines that express DP-1 under the control of tetracycline-responsive expression vectors, and found that ectopic expression of DP-1 inhibited growth and induced apoptosis (Magae et al., 1999) . DP-1 did not induce S phase entry in these cells. Inactivation of the proteasome by ectopic DP-1 was implicated since ubiquitinylated proteins including p21 and c-Jun were markedly increased in DP-1 expressing cells. In this report, we describe a Chinese hamster cell line that expresses E2F-4 in tetracycline-dependent manner. Our results demonstrate that E2F-4 inhibits cell growth and induces apoptosis in a manner distinct from E2F-1 and DP-1.
Results
Establishment of CHOC 400 cells which express human E2F-4 in a tetracycline-responsive manner
We previously established stable CHOC 400 cell lines that conditionally express DP-1 (D1-38) and E2F-1 (E1-12), using the bacterial tetracycline repressor system (Magae et al., 1999) . In a similar fashion we established CHOC 400 cells that conditionally express E2F-4 under the control of a tetracycline-responsive expression system. Cells cotransfected with an expression plasmid for human E2F-4 and the pUHD15.1-neo tetr-VP16 regulator plasmid were selected in 0.4 mg/ml G418 for 20 days. The resulting G418-resistant colonies were cloned by limiting dilution, tested for tetracyclineregulated expression by immunostaining for E2F-4, and one clone that showed tight control of E2F-4 expression in response to tetracycline (E4-4) was selected for further study. E4-4 expressed E2F-4 protein upon the removal of tetracycline in a dosedependent fashion. Expression was induced at concentrations below 1 ng/ml tetracycline, and within 8 h after removal of tetracycline ( Figure 1a ). Prolonged incubation detected slight amount of E2F-4 at 10 ng/ ml tetracycline (data not shown). E2F-4 expressed after removal of tetracycline was predominantly present in cytoplasm (Figure 1b) , as reported for transient transfection experiments previously (Magae et al., 1996) .
Growth inhibition by the ectopic expression of E2F-4
Induction of E2F-4 (as well as E2F-1 and DP-1) by the removal of tetracycline inhibited the growth of Chinese hamster cells (Figure 2a ). The growth inhibition was dependent on the concentration of tetracycline ( Figure   Figure 2b), and slight inhibition was oberved even at 100 ng/ ml tetracycline where E2F-4 was not detected on Western blotting shown in Figure 1a , indicating that small amounts of ectopically expressed E2F-4 could aect the growth of CHOC 400. During growth arrest by expression of E2F-1, E2F-4 and DP-1, a fraction of cells rounded up and detached from the plate ( Figure  3) . By 24 h after removal of tetracycline, alterations in cell morphology were evident; by 48 ± 72 h the cells subsequently shrank and died. These observations suggested that ectopic expression of E2F-4 and DP-1 induced apoptosis of CHOC 400 cells, as has been previously reported for E2F-1 in other cell types (Wu and Levine, 1994; Qin et al., 1994; Shan and Lee, 1994) . The growth inhibitory eect was studied further in synchronized cells (Figure 4 ). When cells were cultured in low serum for 48 h, more than 80% cells were in G0/G1 phase. Addition of 5% fetal bovine serum (FBS) caused cells to re-enter the cell cycle. Flow cytometry indicated S phase started 12 ± 16 h later. Ectopic expression of E2F-1 in quiescent Chinese hamster cells induced S phase entry in the absence of FBS, and enhanced S phase entry by 5% FBS, as reported by the other groups (Johnson et al, 1993 , DeGregori et al., 1997 . On the other hand, ectopic expression of DP-1 did not promote S phase entry of quiescent cells, and partially arrested cells in G1 phase in the presence of 5% FBS (Magae et al., 1999) . Induction of E2F-4 neither induced S phase in the absence of serum, nor did it arrest cells in G1. Rather it slightly retarded S phase progression after stimulation with serum. Thus, expression of E2F-4 inhibited the growth of CHOC 400 cells by a mechanism distinct from that of E2F-1 and DP-1.
Apoptosis of CHOC 400 cells expressing E2F-4
The morphological changes observed in Figure 4 indicated that E2F-4 expression inhibited the growth of E4-4 cells by inducing apoptosis. DNA samples from nuclei-free cell lysates were prepared from cells grown in the absence or presence of tetracycline for 1 ± 3 days and resolved by agarose gel electrophoresis ( Figure 5 ). DNA ladders indicative of fragmentation of chromosomal DNA into nucleosome-sized unit (186 bp) were observed 24 h after the removal of tetracycline in the cell lines expressing DP-1, E2F-1 and E2F-4, but not in the parent cell line, CHOC 400. Less fragmentation was observed after expression of DP-1 than either E2F-1 or E2F-4. Maximum DNA fragmentation was detected 48 h after induction, and persisted until at least 72 h. DNA fragmentation was not observed in samples from cells grown in the presence of tetracycline. This result indicates that ectopic expression of E2F-4, like that of E2F-1, induces apoptosis in CHOC 400 cells. Apoptosis by E2F-4 was also indicated by morphological features of Eect of ectopic expression of E2F-4 on cell cycle progression of CHOC 400 cells. Cells were arrested in G0/G1 by culturing in the medium containing 0.1% FBS for 48 h. Fresh medium containing 0.1% or 5% FBS then was added to each dish (time 0 h) with or without tetracycline (1 mg/ml) for the indicated period of time. Cell cycle progression was assessed by¯ow cytometry nuclei stained with DAPI ( Figure 6 ). E4-4 cells cultured in the absence of tetracycline for longer than 48 h bore segmented and condensed nuclei, a typical morphological change for apoptotic cells. We noted that E2F-4 expression in the cytoplasm was reduced in some apoptotic cells, presumably because E2F-4 in apoptotic cells was degraded by the proteasome as reported previously (Hateboer et al., 1996) .
The amount of apoptosis in E4-4 cells was quanti®ed by measuring tritium release from cells labeled with 3 Hthymidine (Figure 7 ). Release of [ 3 H]thymidine from nuclei was signi®cantly increased by expression of E2F-4. Expression of DP-1 induced the release of less radioactivity than expression of either E2F-1 or E2F-4, a result consistent with the DNA fragmentation assays shown in Figure 4 . z-VAD-Fmk, a caspase inhibitor with broad activity against various caspases, reduced the level of tritium release to less than the level observed in the presence of tetracycline. In contrast, the calpain inhibitor z-FA-Fmk had no eect on tritium release. This result suggests that apoptosis of CHOC 400 cells induced by DP-1, E2F-1 and E2F-4 is caspase-dependent.
E2F-4 affects cell cycle progression differently than E2F-1 or DP-1
Result of cell cycle analysis in Figure 4 suggested that E2F-4 induced apoptosis and growth inhibition by a mechanism dierent from DP-1 and E2F-1. To examine the eects of E2F-4 on cell cycle, we ®rst examined the expression of c-Jun by immunoblotting. As reported previously (Magae et al., 1999) , DP-1 increased the levels of c-Jun as a result of inhibition of the proteasome (Figure 8 ). Increased c-Jun was associated with high molecular bands which represent polyubiquitinylated forms of c-Jun. In contrast to DP-1, ectopic expression of either E2F-1 or E2F-4 did not aect the expression of c-Jun.
E2F DNA binding activity in E4-4 cells was assessed using gel mobility shift experiments using the conserved overlapping E2F sites of the dhfr promoter as a probe (Figure 9 ). Ectopic expression of DP-1 did not aect Figure 5 Ectopic expression of E2F-4 induces DNA fragmentation. One million of cells were incubated with or without tetracycline (1 mg/ml) for the indicated time, and DNA was analysed for fragmentation with agarose gel electrophoresis as described in Materials and methods H-thymidine were cultured for 48 h with indicated the reagents (tetracycline 1 mg/ml; z-VAD-Fmk, 0.1 mM; z-FA-Fmk, 0.1 mM), and per cent of tritium release was determined the DNA binding pro®le of E2F as reported before (Magae et al., 1999) , and Rb/E2F-1/DP-1 complex (band C) accumulated in whole cell lysates of E1-12 cells upon expression of E2F-1. Induction of complex C was accompanied by decreases in other E2F DNA binding complexes. In E4-4 cells, E2F-4 expression increased the binding of complex D, which is composed of E2F-4 and DP-1 (Wells et al., 1996 (Wells et al., , 1997 . Band A composed of complexes containing E2F-4 and p107 was not aected by the ectopic expression of E2F-4. Bands B and C containing p130 and pRb (Wells et al., 1996 (Wells et al., , 1997 were not visible in this experiment.
This result showed ectopic E2F-4 was able to associate with endogenous DP-1 in cell extracts and bind E2F sites in vitro, which prompted us to study the eect of E2F-4 on E2F-dependent transcription activity. Transcription activity as detected by luciferase reporter bearing four E2F binding motifs was much higher in E1-12 cells, even in the presence of tetracycline, as compared to E4-4 cells (Figure 10a ). Remarkably the induction of either E2F-1 or E2F-4 at levels which altered E2F DNA binding activity had minimal eect on reporter gene activity. In addition, expression of E2F-4 did not aect the transcription of the endogenous hamster dhfr and pcna genes ( Figure  10b ), both of which are considered downstream targets of E2F (DeGregori et al., 1995; Huang and Prystowsky, 1996; Blake and Azizkhan, 1989; Wade et al., 1992) . These results suggest that growth inhibition and apoptosis of CHOC 400 cells induced by E2F-4 may be independent of E2F-dependent transcriptional activation of E2F target genes.
Discussion
The pRb/E2F pathway plays a central role in cell cycle progression and apoptosis. Although numerous experiments indicate E2F-1 is able to induce apoptosis (reviewed by Adams and Kaelin, 1996) , the ability of other E2F family members to induce apoptosis is unclear. We found this issue dicult to examine in transiently transfected cells if the factor in question suppresses cell growth, or manifests its activity after 48 h. We therefore have generated stable cell lines expressing several E2F-family members for such studies. The tetracycline-o expression system (Gossen and Bujard, 1992 ) is well behaved in CHOC 400 cells: for cell lines expressing E2F-1, DP-1 or E2F-4, protein expression is regulated as a function of tetracycline concentration and time (Magae et al., 1999 and Figure  1 ). Previous studies show that E2F-1 and E2F-4 have distinct structural and functional characteristics. E2F-1 has a cyclin A binding domain, localizes in nucleus when expressed in transfection experiments, and preferentially binds pRb. E2F-4 has no cyclin A binding domain, localizes in cytoplasm when expressed in transfected cells, and binds preferentially to p107 and p130 (reviewed by Dyson, 1998) . In CHOC 400 cells, an E2F-1 containing DNA binding complex appears in late G1 in serum-stimulated cells, while the majority of the E2F complex detected in serum deprived cells includes E2F-4 and p130 (Wells et al., 1997) .
Here we have observed dierences in cell growth after the expression of E2F-1 and E2F-4. In contrast to E2F-1, which is localized in nucleus of E1-12 cells (Magae et al., 1999) , E2F-4 induced by the removal of tetracycline localized in cytoplasm and did not drive quiescent cells into S phase. Rather E2F-4 retarded S phase progression slightly after serum stimulation. In cells expressing E2F-1, the majority of E2F-1 was associated with DP-1 and pRb (band C) as detected by Figure 8 Eect of E2F family proteins on c-Jun expression. Cells were cultured in the presence or absence of tetracycline (1 mg/ml) for 24 h. Cell lysates were subjected on Western blotting, using a monoclonal antibody for c-Jun, KH20 for E2F-1 (E1-12), WTH10 for DP-1 (D1-38), and a polyclonal antibody C-20 for E2F-4 (E4-4) Figure 9 DNA binding complexes in cells expressing E2F-1 and E2F-4. Whole cell lysates from log-phase CHOC 400, D1-38, E1-12 and E4-4 cultured for 24 h with the indicated concentrations of tetracycline were analysed for E2F DNA binding activity by electrophoretic gel mobility shift assays using the overlapping E2F sites at the dhfr promoter as probe. The components of each band were determined by supershift experiments, as reported previously (Wells et al., 1997; Magae et al., 1999) Figure 10 Eect of E2F expression on E2F-dependent transcriptional activity in CHOC 400 cells. (a) E4-4 and E1-12 were transfected with an E2F reporter and pCMV-b-gal, and reporter enzyme activity were determined 24 h after removal of tetracycline as described in Materials and methods. CAT activity normalized to b-galactosidase activity is shown. (b) E4-4 cells were cultured with or without tetracycline (1 mg/ml) for 24 h. Expression of mRNA was determined by Northern blotting gel retardation experiment, whereas E2F-4/DP-1 complex (band D), but neither p107/DP-1/E2F-4 (band A), p130/DP-1/E2F-4 (band B) nor pRb/DP-1/E2F-4 (band C) increased in E4-4 cells after the induction of E2F-4. In contrast to DP-1 (Magae et al., 1999) , in serum response experiments E2F-4 did not halt cells in G1 by inactivation of the proteasome. DP-1 but not E2F-1 and E2F-4 induced c-Jun accumulation, a typical target of ubiquitination (Treier et al., 1994) . However, ectopic expression of E2F-4 did induce growth inhibition and apoptosis. These results suggest that the pathway leading to apoptosis by E2F-4 appears dierent from those induced by elevated levels of E2F-1 and DP-1.
E2F suppresses downstream target genes by recruiting pRb family proteins which subsequently repress gene expression (Weintraub et al., 1992 (Weintraub et al., , 1995 Sellers et al., 1995; Adnane et al., 1995; Bremner et al., 1995; Ferreira et al., 1998) . It is conceivable that accumulation of the pRb/DP-1/E2F-1 complex in E1-12 cells induces cell cycle arrest and then apoptosis. Cell cycle analysis of synchronized cells showed that S phase entry induced by serum stimulation and expression of E2F-1 occurred with similar kinetics. This suggests that ectopic E2F-1 may trigger progression of quiescent cells into the growth cycle by relieving repression of gene expression, not by providing E2F-1 which normally is induced by serum stimulation at G1/S boundary. He et al. (2000) demonstrated that E2F is required for the maintenance of quiescent state, but not for the G1/S transition. Therefore the critical event triggering exit from the quiescent state may be the release of E2F-mediated transrepression, not transactivation by E2F (He et al., 2000) . We suggest ectopic expression of E2F-1 may promote S phase of quiescent cells by the release the transrepression complex containing pocket proteins, but after the onset of cell cycle progression, it then accumulates in a complex with endogenous pRb, which subsequently induces growth inhibition and apoptosis.
Several typical properties of apoptosis were observed in E4-4 cells cultured without tetracycline: cells rounded up, shrank in size, and detached from the plate after 24 ± 48 h of E2F-4 expression. Chromosomal DNA was digested into characteristic nucleosomalsized fragments, and nuclei of cells were condensed and segmented. Apoptosis of E4-4 cells was suppressed by a caspase inhibitor, z-VAD-Fmk, suggesting that a caspase-dependent pathway is involved in the process. Ectopic expression of E2F-4 in serum starved cells did not induce S phase, in agreement with the work of others (DeGregori et al., 1997; Dirks et al., 1998) . It is reported that only E2F-1 but not other E2F family proteins induce apoptosis of cells (DeGregori et al., 1997) . Gene disruption of E2F-1 but not of E2F-5 showed impaired apoptosis and abnormal maturation of T cells (Yamasaki et al., 1996; Field et al., 1996; Lindeman et al., 1998) . On the other hand, several groups have reported that ectopic expression of E2F family proteins other than E2F-1 also induce apoptosis (Bargou et al., 1996; Dirks et al., 1998) , which is consistent with our present result.
The majority of E2F-4 induced by the removal of tetracycline localized in cytoplasm of E4-4 cells, as shown previously with transient transfection experiments (Magae et al., 1996) . Although the free E2F-4/ DP-1 complex (band D) was increased by expression of E2F-4, reporter gene experiments demonstrated that E2F-dependent transcriptional activity was only slightly increased by E2F-4 induction. Since we used whole cell extracts for the gel shift experiment, E2F-4/ DP-1 complexes in the cytoplasm would be detected in gel shift experiments. Transcription activation would require translocation of E2F-4 into the nucleus, perhaps by DP-2, a heterodimeric partner which has a nuclear localization signal (de la Luna et al., 1996) , as reported by other groups (Lindeman et al., 1997; MuÈ ller et al., 1997; Verona et al., 1997) . In addition, transcription of the pcna and dhfr genes, downstream targets of E2F (DeGregori et al., 1995; Huang and Prystowsky, 1996; Blake and Azizkhan, 1989; Wade et al., 1992) , were not signi®cantly aected by the ectopic expression of E2F-4. Together these results indicate that elevated levels of E2F-4 induce apoptosis, but not through induction or repression of E2F-dependent gene expression. The defect in cell growth may be related to the interruption of other cell growth control pathways by the accumulation of cytoplasmic (or nuclear) E2F-4. It is possible that cytoplasmic E2F-4 binds to and sequesters cell cycle regulators including Rb family proteins, cycline dependent kinases and their inhibitors. The precise mechanism for apoptosis and growth inhibition induced by ectopic expression of E2F-4 is now under investigation.
Materials and methods

Cell culture
The methotrexate-resistant Chinese hamster ovary cell line CHOC 400, which bears an ampli®ed DNA region containing reiterated dhfr genes (Milbrandt et al., 1981) , was cultured at 378C in a humidi®ed 5% CO 2 atmosphere using D-MEM supplemented with 50 mg/ml kanamycin and 5% FBS (Gibco). Cell lines bearing tetracycline-responsive expression plasmids were kept as frozen aliquots after cloning. Aliquots were thawed 10 days before experiments and cultured in medium containing 1 mg/ml tetracycline. Plasmids for constitutive expression vectors for luciferase (pGL-luc) and bgalactosidase (pCMV-b-gal) were kind gifts from Dr Brooke Mosman (University of Vermont, Burlington, VT, USA) and E2F reporter (pGL3-E2Fx4-TATA basic-luciferase) were from Dr Kristian Helin (European Institute of Oncology, Milan, Italy).
Construction of plasmids and cell lines
Tetracycline-responsive plasmids, UHD15-1 and pUHD10-3, were a gift from H Bujard (UniversitaÈ t Heidelberg, Germany (Gossen and Bujard, 1992) . cDNAs for hemagglutinin (HA)-tagged human E2F-1, DP-1, and non-tagged E2F-4 were inserted into the BamH1 site of pUHD10.3 by standard methods. Tetracycline-regulated expression plasmids were cotransfected with pUHD15-1-neo as described previously (Magae et al., 1999) . After the selection in medium containing 0.4 mg/ml G418 and 1 mg/ml tetracycline for 2 ± 3 weeks, single colonies were isolated by the limiting dilution in 96 well plates in the presence of tetracycline.
Immunoblotting
Immunodetection of protein expression was performed as described previously . In brief, cells were lysed in 26SDS sample buer containing 100 mM dithio-threitol, and uniform amounts of each sample were resolved by electrophoresis in SDS denaturing polyacrylamide gels. Proteins in the gel were transferred to Immobilon-P membranes (Milipore). Blots were blocked in 5% non-fat dry milk in TBS-T (Tris-buered saline: 20 mM Tris, 0.8% NaCl, 0.1% Tween 20, pH 7.5), probed with the indicated primary antibodies, and then with the appropriate horse radish peroxidase-coupled secondary antibody (Amersham). Signals were detected by the ECL system (Amersham).
Immunofluorescent microscopy
Cells on cover slips were ®xed with 2% paraformaldehyde in PBS, permealized with 0.1% Triton X-100 in PBS and stained with a rabbit polyclonal antibody for E2F-4 (1 mg/ml) for a primary antibody, and¯uorescent dye-conjugated antirabbit immunoglobulin antibody for secondary antibodies (1/ 100 dilution, Amersham) as described previously (Magae et al., 1996) . After the immunostaining, cellular DNA was stained with 4,6-diamidino-2-phenylindole (DAPI) at 10 ng/ ml.
Cell cycle analysis by flow cytometry
Flow cytometry was used for cycle analysis as described previously (Magae et al., 1999) . For synchromy experiments, cells were cultured in medium containing 0.1% FBS for 48 h to arrest cells in G0/G1, and were then induced to re-enter the cell cycle by addition of medium with 5% FBS. To analyse DNA content, cells were washed with PBS, suspended in 4 mM sodium citrate containing 0.1% Triton X-100, 32 mg/ml RNAse A, and 50 mg/ml propidium iodide. DNA content was analysed by¯ow cytometry (Epics XL, Coulter).
DNA fragmentation assays
One million cells were suspended in 0.1 ml of lysis buer (10 mM Tris, 10 mM EDTA, 0.5% Triton X-100, pH 7.4) for 15 min on ice, centrifuged at 15 000 r.p.m. for 10 min. The supernatant was mixed with 25 ml 5 M NaCl and 250 ml isopropanol, kept at 7208C overnight, centrifuged at 15 000 r.p.m. for 10 min. The precipitate was washed with 80% ethanol once and suspended in 20 ml TE (10 mM Tris, 1 mM EDTA, pH 8.0). The sample was analysed on 2% agarose gel in TBE buer (89 mM Tris, 89 mM boric acid, 2 mM EDTA). % tritium release total cXpXmX À experimental cXpXmX total cXpXmX Â 100
Gel shift assays
Gel mobility shift assays were carried out as described previously (Wells et al., 1996 (Wells et al., , 1997 . In brief, cells were lysed in high salt buer (100 mM HEPES, pH 7.4, 500 mM KCl, 5 mM MgCl 2 , 0.5 mM EDTA, 35% glycerol, 5 mM NaF, 2 mg/ml PMSF, 0.1 mg/ml aprotinin, 0.1 mg/ml leupeptine, and 1 mM DTT), and centrifuged at 300 000 r.p.m. for 15 min. The resulting whole cell extracts were mixed with 32 Plabeled probe and salmon sperm DNA as non-speci®c carrier for 10 min in room temperature. Protein-DNA complexes were resolved on neutral 4% polyacrylamide gels in 0.256TBE and visualized by autoradiography. The sequence of the top strand of the oligonucleotide probe was: 5'-CCGGG CGAATGCAATTTCG CGCCAAA CTTGGGGG-AAGC-3' which contained two overlapping binding sites in the context of native¯anking sequence of dhfr promoter in CHOC 400 cells.
Reporter gene assays
Cells (3610 5 cells/plate) were cotransfected with E2F reporter plasmid and pCMV-b-gal by the calcium precipitation method, as described before. Sixteen hours after the transfection, cells were washed with PBS three times, further cultured in fresh medium for 24 h, and the scraped cells were suspended in 0.1 ml lysis buer (Boehringer). The bgalactosidase activity in cell lysates was determined by absorbance at 415 nm after the incubation with 7 mM onitrophenol-b-D-galactopyranoside in PBS. CAT activity was determined with a commercial ELISA assay kit (Boehringer).
Northern blotting
Total RNA was isolated from the cells with Trizol reagent (Gibco). Northern blotting was carried out as described previously (Shull et al., 1991) . RNA gels were loaded with 15 mg RNA per lane.
Antibodies
Monoclonal antibodies KH20 (anti-human E2F-1) and WTH10 (anti-human DP-1) have been described previously (Helin et al., 1993; Wu et al., 1995) . A polyclonal rabbit anti-E2F-4 antibody (C-20), a monoclonal anti-c-Jun antibody were purchased from Santa Cruz and Transduction Lab.
